Sleep drug tested for violent dream disorder
NCT ID NCT05922995
Summary
This small, early-stage study aimed to see if a daily dose of the drug tasimelteon could help people with REM Behavior Disorder (RBD). RBD causes people to physically act out their dreams, which can lead to injury. The study measured if the drug reduced these dream enactment events and improved sleep quality for 20 participants, but it was terminated early.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REM BEHAVIOR DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.